
Onconano Medicine
Developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease.
Employees
Enterprise value
$250m
Authorizing premium user...
Developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease.